Epileptic responses in marmosets induced by knockdown of CREB Regulated Transcription Coactivator 1 (CRTC1)

Yuki Nakagami, Misako Komatsu, Ken Nakae, Masanari Otsuka, Junichi Hata, Hiroaki Mizukami, Hiroshi Takemori, Shin Ishii, Hideyuki Okano, Akiya Watakabe, Tetsuo YamamoribioRxiv 2023 · DOI

TL;DR

Researchers have developed a novel marmoset model of epilepsy by knocking down the CRTC1 gene in the visual cortex. This model exhibits epileptic responses, brain lesions, and network changes, offering a new platform to study epileptogenesis and test potential treatments for focal and structural epilepsy.

What Problem Does This Paper Address?

Epilepsy affects a significant portion of the global population, yet a substantial percentage of patients remain refractory to current treatments. Understanding the underlying biological mechanisms of epilepsy is crucial for developing more effective therapies. While animal models have been instrumental in advancing epilepsy research, there's a continuous need for models that accurately represent the diverse subtypes of epilepsy and allow for real-time study of the disease's progression from onset to remission. This paper addresses this need by creating a new marmoset model that mimics focal and structural epilepsy, enabling detailed investigation of its development and potential therapeutic interventions.

Methods

The study employed a multi-pronged approach to induce and characterize epilepsy in marmosets. Key techniques included:

  • CRTC1 Knockdown (KD) via shRNA: Short hairpin RNA (shRNA) targeting the CREB Regulated Transcription Coactivator 1 (CRTC1) gene was delivered to the primary visual cortex (V1) of marmosets using Adeno-Associated Virus (AAV) vectors. This was done at multiple sites to achieve effective gene knockdown.
  • Electrocorticography (ECoG): Cortical-wide neural activity was monitored longitudinally using ECoG recordings to detect high-frequency oscillations (HFOs), a biomarker for epileptic foci.
  • Magnetic Resonance Imaging (MRI): Both in vivo and ex vivo MRI (including T2-weighted and diffusion MRI) were used to assess structural changes in the brain, such as lesions and alterations in white matter connectivity.
  • Histological Analysis: Postmortem histological techniques, including Nissl staining, TUNEL staining (for cell death), and immunohistochemistry (for markers of neuronal and glial activity like NeuN, GFAP, and IBA1), were used to examine tissue damage, cell death, and glial activation at the injection sites and other brain regions.
  • Gene Expression Analysis: In situ hybridization (ISH) and immunohistochemistry (IHC) were used to assess the expression of immediate early genes (IEGs) like cFOS, ARC, and NUR77, which are indicators of neuronal activity.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • CRTC1 KD as an Epilepsy Inducer: Knocking down CRTC1 in the visual cortex of marmosets is sufficient to induce epileptic responses, suggesting a critical role for this gene in regulating neuronal excitability and preventing seizures.
  • Widespread Neural and Structural Changes: The induced epilepsy wasn't confined to the injection site. It led to widespread changes in cortical activity (HFOs), abnormal functional connectivity, and structural lesions, particularly in the temporal lobe.
  • Epileptogenesis Progression: The model allows for the observation of the entire epileptic process, from initial seizure onset and spread to eventual remission, providing a unique window into the dynamics of epileptogenesis.
  • Glial Involvement: The study highlighted the role of glial cells (astrocytes and microglia) in the development of epilepsy, showing their activation and involvement in tissue repair and potentially in the progression of the disease.
  • Functional Network Reorganization: The epilepsy model demonstrated significant reorganization of functional brain networks, with initial disruptions followed by a stabilization of connectivity, offering insights into how the brain adapts to chronic epileptic activity.

Key Results

  • Three-site injection of shCRTC1#1 into marmoset V1 induced epileptic responses that spread throughout the cortex.
  • Longitudinal ECoG recordings revealed the induction of cortical-wide HFOs (cwHFOs) originating around the injection site and spreading to the temporal cortex and lobe.
  • MRI and histological analyses confirmed the presence of lesions in the temporal lobe and surrounding the injection sites, along with evidence of neuronal loss and glial activation.
  • The study observed a significant reduction in V1-V1 functional connectivity immediately after injection, which reorganized to a stable level within five weeks.
  • Ex vivo dMRI revealed increased lateral asymmetry in connectivity in the injected marmosets compared to normal controls.
  • The epileptic symptoms in this model showed remission within a few months after injection, with a significant decrease in cwHFO frequency.

Limitations and Future Work

  • Off-Target Effects: A potential limitation is the possibility of off-target effects of shCRTC1#1, although the authors argue this is unlikely due to the high selectivity of the shRNAs for the CRTC1 gene. Further studies are needed to precisely understand the interactions between different shCRTC1 variants.
  • Causal Relationship: The causal relationship between cell death and IEG induction remains unclear, with the authors suggesting an interdependent relationship. Future work could explore this balance at the molecular and cellular levels.
  • Confirmation of Status Epilepticus: While the study suggests that CRTC1 injection could lead to a situation similar to status epilepticus, this needs to be confirmed.
  • Further Investigation of shCRTC1 Variants: The study identified different effects of various shCRTC1 variants, with some leading to more widespread IEG induction and others to more tissue damage. Further investigation into how these variants act at the molecular and cellular level is warranted.

Summary updated

Abstract

Summary Animal models have contributed greatly to the development of anticonvulsant drugs. However, 20-30% of epilepsy patients still do not achieve adequate seizure control. It is important to understand the biological mechanisms of epilepsy in order to develop treatments and novel anticonvulsant drugs. Here we report CRTC1 knockdown (KD) induced abnormal cFOS expression beyond the injection sites followed by epileptic response by three local injections of short hairpin RNA (shRNA) in marmoset V1. Longitudinal monitoring of cortical-wide neural activity revealed transient changes in high frequency oscillations by cortical electrocorticography throughout the cortex, and a lesion in the temporal lobe was observed by MRI and postmortem histology. shCRTC1 KD marmosets showed severe lesions surrounding the injection site several months after injection. Glial cell activation may occur simultaneously or prior to IEG induction after shCRTC1 injection. Thus, the epileptic process from seizure onset to remission can be studied in this animal model.
BibTeX
@misc{nakagami2023epileptic,
  author = {Yuki Nakagami and Misako Komatsu and Ken Nakae and Masanari Otsuka and Junichi Hata and Hiroaki Mizukami and Hiroshi Takemori and Shin Ishii and Hideyuki Okano and Akiya Watakabe and Tetsuo Yamamori},
  title = {{Epileptic responses in marmosets induced by knockdown of CREB Regulated Transcription Coactivator 1 (CRTC1)}},
  year = {2023},
  doi = {10.1101/2023.09.22.558929},
  howpublished = {bioRxiv},
}
Figure